Skinbiotherapeutics has an EPS of $-0.0172. In 2022, the company made an earnings per share (EPS) of $-0.0178. Earnings Per Share (EPS) is a financial metric that measures a company's profit allocated to each outstanding share of its common stock. It is calculated by dividing the company's net earnings by the number of outstanding shares.
Year | EPS | Change |
---|---|---|
2023 | -$0.0172 | -3.37% |
2022 | -$0.0178 | 81.63% |
2021 | -$0.0098 | -16.24% |
2020 | -$0.0117 | - |